NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference
|
| Posted
:
Thu, 29 Oct 2009 16:05:29 GMT |
| Author
:
Novavax, Inc. |
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
ROCKVILLE, Md., Oct. 29 MD-NOVAVAX-Op-Conf
ROCKVILLE, Md., Oct. 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Oppenheimer 20th Annual Healthcare Conference. Dr. Singhvi's presentation will take place at 3:20 pm local time on November 3, 2009 at the Waldorf=Astoria, New York, NY. Dr. Singhvi will provide an overview of the company's business strategy and research and development progress. A link to the live presentation can be accessed via the Company website at www.novavax.com under the Investors tab. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.
About the Oppenheimer 20th Annual Healthcare Conference
The Oppenheimer 20th Annual Healthcare Conference will take place at the Waldorf=Astoria in New York City, November 3-4, 2009. This conference will present a core group of public and private companies who are leaders and pioneers in the pharmaceutical, biotechnology, medical device, healthcare facility, health technology and distribution, provider and service industries. Over 19 years, the Oppenheimer Healthcare Conference has become a highly valuable investor conference in this sector. Through formal company presentations and panels, attendees will gain insight from, and access to, industry leaders.
The Companies participating in this conference will address topical issues such as health reform, Medicare and Medicaid, generic drug regulation, development of new blockbuster pharmaceutical and biotechnology products, product safety and patent issues, cross-border reimportation, Food and Drug Administration policy, managed care, and the current M&A environment.
About Novavax
Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP -based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The Company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: www.novavax.com
SOURCE Novavax, Inc.
|
Copyright © 2008
PR Newswire. All rights reserved.
|
|
|
|
|
Related
News
Nashville's PAI Medical Group Hair Transplant Procedure Guarantee Update
PAI Medical Group of Tennessee is offering their patients a regrowth guarantee with every hair transplant procedure. This is a guarantee on results with less restrictions than ever before./I/P
P(PRWEB) November 26, 2009 -- For nearly 15 years, this world renowned hair transplant clinic ...
The Who to Perform February 7 During the Bridgestone Super Bowl XLIV Halftime Show on CBS
NEW YORK, Nov. 26 /PRNewswire/ -- THE WHO, one of the world's greatest and most dynamic rock and roll bands, will perform in the BRIDGESTONE SUPER BOWL XLIV HALFTIME SHOW on CBS Sports at Dolphin Stadium in South Florida on Sunday, February 7, the NFL announced today durin...
VRX Worldwide Announces Change of Auditor
VANCOUVER, BRITISH COLUMBIA -- 11/26/09 --
VRX Worldwide Inc. (TSX VENTURE: VRW) announced today that Price Waterhouse Coopers LLP ("PWC") resigned as auditor of the Company and that Cinnamon Jang Willoughby & Co. ("CJW") has been appointed as ..
New Pacific Metals Corp. Announces Results for the Three Months Ended September 30, 2009
VANCOUVER, BRITISH COLUMBIA -- 11/26/09 --
New Pacific Metals Corp. (TSX VENTURE: NUX) (the "Company") announces its unaudited consolidated financial results for the three months ended September 30, 2009. All figures are expressed in Canadian dolla..
Diadem Announces Equity Financing to Raise Up to $750,000
MONTREAL, QUEBEC -- 11/26/09 --
Diadem Resources Ltd. (TSX VENTURE: DRL)("Diadem" or the "Company") announced today that it proposes to effect a non-brokered private placement of up to 15,000,000 Units at $0.05 per Unit to raise up to $750,000 of e..
World Food Funds Franchisor
Jorgan’s Foods, Inc. turned to World Food Association Organization to secure $12.6 million to refinance existing loans. The financing extinguishes 25 existing loan agreements before their scheduled maturity and is secured by existing real estate and business value. /I/P
PScottsdal...
Dianor Announces Closing of Private Placement
VAL-D'OR, QUEBEC -- 11/26/09 --
Dianor Resources Inc. (TSX VENTURE: DOR) announces that it has completed a private placement by issuing an aggregate of 8,292,138 "flow-through" units to accredited investors in Saskatchewan and Nova Scotia and to th..
|
|
|
|
|
|
|
|
|
